---
title: 'Senior Strategic Account Manager - Omaha at Replimune'
canonical: 'https://feeny.ai/job/senior-strategic-account-manager-omaha-replimune-woburn-zd29jhn75tz0'
type: 'job'
last_seen: '2026-09-09'
---

# Senior Strategic Account Manager - Omaha at Replimune

- **Company:** Replimune
- **Location:** Woburn, MA
- **Employment:** full-time
- **Work type:** remote
- **Posted:** 2026-08-28
- **Last confirmed live:** 2026-09-09
- **Apply:** https://jobs.ashbyhq.com/replimune/269a53f9-4031-40a2-84b6-a69a669d8c01

## Job description

## Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.

Audacious: We Are Bold.

Dedicated: We Give Our Full Commitment.

Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Position Summary

Replimune is seeking a highly motivated and proactive Strategic Account Manager (SAM) to support the launch of an innovative therapy for patients with advanced cutaneous melanoma. This individual will be responsible for driving account strategy, building collaborative partnerships across multidisciplinary oncology teams, and optimizing patient access and care pathways within key treatment centers.

The successful candidate will have a strong background in oncology account management, demonstrated success navigating complex healthcare systems, and experience coordinating care across multidisciplinary teams. Experience in interventional radiology sales or working closely with interventional oncology teams is highly desirable.

This is a field-based position. Candidates must generally reside within the territory for which they are applying.

## Key Responsibilities

- Develop and execute strategic account plans for priority melanoma treatment centers and integrated delivery networks.
- Establish trusted partnerships with key stakeholders, including Medical Oncology, Surgical Oncology, Interventional Radiology, Radiation Oncology, Pharmacy, Nursing, Advanced Practice Providers, Care Coordinators, and Administrative Leadership.
- Identify opportunities to improve coordination of patient care across the multidisciplinary team to support timely treatment decisions and appropriate patient access.
- Map patient treatment pathways and understand referral patterns, diagnostic workflows, and institutional decision-making processes.
- Collaborate cross-functionally with Medical Affairs, Market Access, Marketing, Patient Services, and Field Reimbursement teams to execute account strategies.
- Apply critical thinking and strategic problem-solving to address barriers impacting patient identification, treatment adoption, and operational execution.
- Support disease state education and appropriate product adoption while maintaining compliance with all regulatory and company policies.
- Analyze account performance, market dynamics, and competitive activity to refine territory strategy and maximize launch success.
- Build long-term relationships with key opinion leaders and influential stakeholders across assigned accounts.
- Utilize CRM and business analytics tools to prioritize opportunities and measure execution against key performance indicators.

Required Qualifications

- Bachelor's degree required; advanced degree preferred.
- Minimum of 5+ years of pharmaceutical or biotechnology sales experience, including at least 3 years in oncology account management.

o Experience with melanoma, immuno-oncology, or solid tumor therapeutics is strongly preferred.

o Experience launching oncology products in a specialty or hospital-based environment is strongly preferred.

o Experience selling to or partnering with Interventional Radiology, Interventional Oncology, or related procedural specialties is highly desirable.

- Demonstrated success managing large, complex oncology accounts and influencing multidisciplinary healthcare teams.
- Experience coordinating or supporting patient care across multidisciplinary oncology settings.
- Strong understanding of oncology treatment pathways, referral networks, and institutional decision-making.
- Exceptional strategic planning, analytical, and critical thinking skills.
- Proven ability to influence without authority and collaborate across internal and external stakeholders.
- Excellent communication, presentation, and executive-level relationship management skills.
- Willingness to travel extensively within assigned geography.

Salary Range

Replimune is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $183,000 - $237,000. The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience. Our current organizational needs also play a part in determining your final offer.

At Replimune, base pay is only one part of your total compensation package. The selected candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Replimune also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays including year-end shutdown.

## About Replimune

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com http://www.replimune.com.

We are an Equal Opportunity Employer.

## About Replimune

## Company Overview
- **One-liner**: Replimune is a clinical-stage biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti-tumor response.
- **Entity Type**: Public (ticker not explicitly provided in search results, but company is publicly traded)
- **Headquarters**: Framingham, Massachusetts, USA (with additional locations in Woburn, MA and Oxfordshire, UK)
- **Founded**: 2015
- **Founders**: Robert Coffin, Ph.D. (Founder and Chief Scientist)

## Core Business
- **Primary industry**: Biotechnology – oncology, oncolytic immunotherapy
- **Target customers**: B2B (pharmaceutical partners) and ultimately patients through healthcare providers
- **Mission**: To ignite a systemic immune response to cancer and reshape the future of cancer care

## Products & Services
- **RPx Platform**: Proprietary, next-generation HSV-1-based oncolytic immunotherapy platform that powers all pipeline candidates.
- **RP1**: Investigational oncolytic immunotherapy for advanced melanoma (IGNYTE trial, PDUFA date April 10, 2026) and non-melanoma skin cancers; also being studied as monotherapy in organ transplant patients with skin cancer (ARTACUS trial).
- **RP2**: Investigational oncolytic immunotherapy for metastatic uveal melanoma (Phase 2/3 RP2-202 trial) and hepatocellular carcinoma (Phase 2 in combination with atezolizumab/bevacizumab).

## Market Standing
- **Valuation/Market Cap**: Not publicly available in provided sources
- **Key Metric**: Clinical-stage; no approved products yet. Key regulatory milestone: FDA action date for RP1 in advanced melanoma on April 10, 2026.
- **Notable Partners**: Bristol-Myers Squibb (supply of nivolumab), Roche (supply of atezolizumab and bevacizumab) – Replimune retains full commercial rights.
- **Growth Signals**: Completed enrollment in IGNYTE trial; confirmatory IGNYTE-3 trial underway; own 63,000 sq ft U.S. manufacturing facility in Woburn, MA enabling global commercial supply; broad pipeline across multiple solid tumor indications.

## Competitive Advantages
- **Strong IP position**: Wholly-owned, unencumbered RPx platform with broad patent protection.
- **In-house manufacturing**: Dedicated U.S. facility for commercial-scale production, reducing reliance on contract manufacturers.
- **First-mover potential**: Poised to be one of the first oncolytic immunotherapies to reach the market if RP1 gains FDA approval.
- **Full rights retained**: All partnership agreements allow Replimune to keep full commercial rights to its therapies.

## Strategic Focus
- Advancing RP1 toward FDA approval in advanced melanoma (April 2026 PDUFA date)
- Expanding pipeline into additional indications (uveal melanoma, hepatocellular carcinoma, non-melanoma skin cancers)
- Building out commercial infrastructure and manufacturing capabilities
- Exploring combination therapies with checkpoint inhibitors (nivolumab, atezolizumab)

## Why Work Here
- **Culture**: Cross-functional, collaborative, values-driven environment. Employee survey results show 92% proud to work at Replimune, 88% feel they make a positive difference, 78% would recommend the company.
- **Flexibility**: Hybrid and remote work options available depending on role; home office and mobile phone stipend provided.
- **Compensation**: New hire equity grants, generous annual bonus plans, retirement plans with substantial company match (100% vested from day one).
- **Benefits**: Medical, dental, and vision insurance 100% paid by the company.
- **Locations**: U.S. (Woburn, MA and Framingham, MA) and UK (Oxfordshire) – opportunities to work across both sites.

## Sources
1. [Replimune Homepage](https://www.replimune.com/)
2. [Replimune Careers](https://www.replimune.com/careers)
3. [Replimune About Us](https://www.replimune.com/about-us)
4. [Replimune Team](https://www.replimune.com/team)
5. [Replimune Pipeline](https://www.replimune.com/pipeline)

## Other roles at Replimune

- [Director, HR Business Partner](https://feeny.ai/job/director-hr-business-partner-replimune-milton-park-z5a3s7k1jy7g) — Milton Park
- [Executive Director, Market Access and Value](https://feeny.ai/job/executive-director-market-access-and-value-replimune-woburn-nf352x5v48bh) — Woburn, MA
- [Scientist II, Quality Control](https://feeny.ai/job/scientist-ii-quality-control-replimune-framingham-sf1y1pmqxbjw) — Framingham, MA
- [Senior Manager, Data Management](https://feeny.ai/job/senior-manager-data-management-replimune-woburn-kesxh7s9ktmd) — Woburn, MA
- [Operational Excellence Lead I (PharmD)](https://feeny.ai/job/operational-excellence-lead-i-pharmd-replimune-woburn-xt9zv5h9hb19) — Woburn, MA
- [Manufacturing Associate I](https://feeny.ai/job/manufacturing-associate-i-replimune-framingham-a9c083cyq8ms) — Framingham, MA
- [Manufacturing Technician](https://feeny.ai/job/manufacturing-technician-replimune-framingham-b4s89qjyc580) — Framingham, MA
- [Sr. Scientist, Process Development & Technology](https://feeny.ai/job/sr-scientist-process-development-technology-replimune-framingham-h5fn33dyrqr9) — Framingham, MA
- [Manager, Regulatory Operations (Publishing)](https://feeny.ai/job/manager-regulatory-operations-publishing-replimune-woburn-pjc393jvsvg4) — Woburn, MA
- [Sr. Director, Clinical Scientist](https://feeny.ai/job/sr-director-clinical-scientist-replimune-woburn-wx071h2yqddk) — Woburn, MA